Paper Details
- Home
- Paper Details
Incidence of rash after amoxicillin treatment in children with infectious mononucleosis.
Author: Ben TovAmir, Chovel-SellaAluma, LahavEinat, MorOrna, ParetGideon, ReifShimon, RudichHagit
Original Abstract of the Article :
"Ampicillin rash," a phenomenon unique to patients with Epstein-Barr virus acute infectious mononucleosis (AIM) treated with ampicillin, was first reported in the 1960s. The incidence was estimated as being between 80% and 100%, and the figures have not been reviewed since those first accounts. We s...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1542/peds.2012-1575
データ提供:米国国立医学図書館(NLM)
Ampicillin Rash in Infectious Mononucleosis: A Reappraisal of Incidence
Infectious mononucleosis, caused by the Epstein-Barr virus, often presents unique challenges in treatment. This research revisits the phenomenon of 'ampicillin rash,' a well-known complication associated with ampicillin treatment in patients with infectious mononucleosis. The authors sought to determine the current incidence of this rash among children with this condition.
Ampicillin Rash Remains a Significant Risk: A Reappraisal of Incidence
The study findings indicate that ampicillin rash continues to be a significant risk in patients with infectious mononucleosis. The authors conclude that clinicians should be aware of this potential complication and consider alternative antibiotics when treating children with this condition.
Navigating Antibiotic Treatment for Infectious Mononucleosis: A Guide for Clinicians
This research underscores the importance of considering the specific characteristics of each patient and the potential complications associated with different treatment options. The findings provide valuable information for clinicians seeking to optimize antibiotic therapy for infectious mononucleosis.
Dr. Camel's Conclusion
The world of medicine is filled with surprises, and ampicillin rash is a reminder that even well-established treatments can have unexpected consequences. This research provides valuable insights into the current incidence of this complication, helping clinicians make informed decisions about antibiotic therapy for infectious mononucleosis.
Date :
- Date Completed 2013-07-17
- Date Revised 2013-11-21
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.